...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Name Confusion

Agoracom should change the info they have under "Fast Facts" as well.

 

  • NAMEZenith Epigenetics
  •  
  • SYMBOL"ZZXY"
  •  
  • EXCHANGEOTCBB
Share
New Message
Please login to post a reply